Non-alcoholic steatohepatitis and hepatocellular carcinoma: Lessons from hepatocyte-specific phosphatase and tensin homolog (PTEN)-deficient mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue SUPPL. 1, 2007, Pages

  Watanabe, Sumio ^a,b   Horie, Yasuo ^a   Kataoka, Ei ^a   Sato, Wataru ^a   Dohmen, Takahiro ^a   Ohshima, Shigetoshi ^a   Goto, Takashi ^a   Suzuki, Akira ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Mutant mice; PTEN; Steatohepatitis

Indexed keywords

ALCOHOL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME SPECIFICITY; FATTY LIVER; FEMALE; HEPATITIS; HEPATOMEGALY; HISTOPATHOLOGY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

EID: 34249791226     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04665.x     Document Type: Conference Paper

References (13)

1. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999 116 : 1413 19.
2. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998 114 : 842 5.
3. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1 dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 1998 273 : 13 75 8.
4. Li J, Yen C, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997 275 : 1943 7.
5. Yao YJ, Ping XL, Zhang H et al. PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 1999 18 : 3181 5.
6. Hu TH, Huang CC, Lin PR et al. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 2003 97 : 1929 40.
7. Rahman MA, Kyriazanos ID, Ono T et al. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COXII and inducible nitric oxide synthase. Int. J. Cancer 2002 100 : 152 7.
8. Horie Y, Suzuki A, Kataoka E et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 2004 113 : 1774 83.
9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999 94 : 2467 74.
10. Cerutti PA. Oxy-radicals and cancer. Lancet 1994 344 : 862 3.
11. Yu S, Matsusue K, Kashireddy P et al. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 2003 278 : 498 505.
12. Marcus SL, Miyata KS, Zhang B, Subramani S, Rachubinski RA, Capone JP. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl Acad. Sci. USA 1993 90 : 5723 7.
13. Kasai H, Okada Y, Nishimura S, Rao MS, Reddy JK. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res. 1989 49 : 2603 5.